CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
79.66
+1.22 (1.56%)
At close: Oct 14, 2025, 4:00 PM EDT
79.30
-0.36 (-0.45%)
After-hours: Oct 14, 2025, 7:56 PM EDT
CVS Health Stock Forecast
Stock Price Forecast
The 18 analysts that cover CVS Health stock have a consensus rating of "Strong Buy" and an average price target of $81.11, which forecasts a 1.82% increase in the stock price over the next year. The lowest target is $65 and the highest is $103.
Price Target: $81.11 (+1.82%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CVS Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 5 | 5 | 6 |
| Buy | 8 | 8 | 8 | 11 | 11 | 11 |
| Hold | 3 | 3 | 3 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 15 | 15 | 16 | 17 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $82 → $89 | Buy | Maintains | $82 → $89 | +11.72% | Oct 14, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $91 | Strong Buy | Initiates | $91 | +14.24% | Oct 14, 2025 |
| Mizuho | Mizuho | Buy Maintains $76 → $88 | Buy | Maintains | $76 → $88 | +10.47% | Oct 9, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $84 → $103 | Buy | Maintains | $84 → $103 | +29.30% | Oct 7, 2025 |
| Bernstein | Bernstein | Hold Maintains $72 → $77 | Hold | Maintains | $72 → $77 | -3.34% | Sep 5, 2025 |
Financial Forecast
Revenue This Year
398.70B
from 370.66B
Increased by 7.57%
Revenue Next Year
413.97B
from 398.70B
Increased by 3.83%
EPS This Year
6.43
from 3.66
Increased by 75.62%
EPS Next Year
7.22
from 6.43
Increased by 12.31%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 443.1B | 451.6B | |||
| Avg | 398.7B | 414.0B | |||
| Low | 382.8B | 378.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 19.5% | 13.3% | |||
| Avg | 7.6% | 3.8% | |||
| Low | 3.3% | -5.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.83 | 8.19 | |||
| Avg | 6.43 | 7.22 | |||
| Low | 6.10 | 6.42 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 86.5% | 27.4% | |||
| Avg | 75.6% | 12.3% | |||
| Low | 66.5% | -0.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.